Skip to content

Released Aug 6, 2021, before the open

10-Q filed Aug 6, 2021, 37 days after period end · 0001564590-21-041921

Q2 2021 · 10-Q
Revenue$121.39M+66.0% vs Q2 2020+15.0% vs Q1 2021
Net Income$2.42MN/M vs Q2 2020N/M vs Q1 2021
EPS Diluted$0.12N/M vs Q2 2020N/M vs Q1 2021
Gross Profit$93,955,000+88.0%
Operating Income$4,267,000N/M
Operating Cash Flowderived-$2,177,000N/M
Free Cash Flowderived-$6,847,000N/M
Margins · derived
Gross margin77.4%+9.1 pt vs Q2 2020
Operating margin3.5%+32.2 pt vs Q2 2020
Net margin2.0%+27.2 pt vs Q2 2020

What the release said

The release

Same quarter

MetricQ2 2021Q2 2020Q2 2019Q2 2018
Revenue$121.39M$73.14M$115.85M$111.55M
Net Income$2.42M-$18.42M-$547.00K$925.00K
EPS Diluted$0.12-$0.96-$0.03$0.05

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Orthofix Medical Inc. · CIK 884624 · Engraved from SEC EDGAR